The most expensive belief in multiple sclerosis planning is that MS is a short-horizon illness. For most people it is not — median survival is only modestly reduced compared with the general population, and that single fact reverses almost every financial decision a newly diagnosed household is tempted to make. Plans built for a five-year horizon fail at year twenty.
MS planning is difficult for a different reason than the diseases people usually compare it to. The course is unpredictable, relapsing forms often convert to progressive forms years later, the drug costs are among the highest in medicine, and disability arrives gradually enough that households keep deferring decisions until a window has closed. Meanwhile the person doing the planning is frequently in their thirties or forties, decades away from Medicare, and holding employer coverage that will not survive leaving work.
What follows corrects seven widely held wrong beliefs, one at a time, each with the specific rule, program or number that replaces it. Everything is current as of 2026 and names who to confirm with. This is education, not medical, legal or benefits advice — the National MS Society’s navigators, a SHIP counselor and your own CPA and attorney are the people to bring in.
In This Article
- Myth 1: “MS Will Shorten My Life Dramatically, So Plan Short”
- Myth 2: “Disability Benefits Start When I Stop Working”
- Myth 3: “The Drugs Will Bankrupt Us”
- Myth 4: “Long-Term Care Insurance Is Still an Option”
- Myth 5: “MS Makes a Life Insurance Policy Valuable in the Secondary Market”
- Myth 6: “I Should Cash In the Policy to Pay for Care”
- Myth 7: “Nothing Can Be Done Until Things Get Worse”
- Frequently Asked Questions

Myth 1: “MS Will Shorten My Life Dramatically, So Plan Short”
Published clinical literature generally describes a reduction in average life expectancy relative to the general population measured in years, not decades — commonly cited in the range of roughly five to ten years, with wide individual variation and better outcomes in more recent cohorts as treatment has improved. Most people with MS die of the same things everyone else does.
Planning for a short horizon when the horizon is long produces specific, predictable damage: surrendering coverage that cannot be replaced, spending down assets that will be needed for another two decades, taking Social Security retirement early on a wrong assumption, and drawing retirement accounts at a rate that runs out.
What to do instead: build a plan for a normal-length life with an uneven cost curve — moderate costs for years, then step changes when function declines. That means preserving insurability, preserving retirement assets, and preserving optionality rather than converting things to cash early.
The one place the short-horizon assumption is genuinely harmful is life insurance. A person with MS who lets coverage go early, believing it will not be needed, generally cannot buy it back at any price, and gives up an asset that would have been worth something in a secondary market decades later if circumstances changed.
Myth 2: “Disability Benefits Start When I Stop Working”
They do not, and the gap is the single largest cash flow problem in MS planning.
Social Security Disability Insurance has a five-month waiting period from the established onset of disability before the first payment. Medicare entitlement for an SSDI recipient generally begins 24 months after SSDI entitlement starts — the exceptions being ALS and end-stage renal disease, not MS. Put together, that is roughly 29 months from disability onset to Medicare, during which the household needs both income and health coverage from somewhere else.
Multiple sclerosis appears in Social Security’s Listing of Impairments under the neurological listings, and claims are evaluated on documented functional limitation — including the effects of fatigue and cognitive change, which are the hardest to document and the most commonly underweighted.
What to do instead: file early rather than waiting until work is impossible; document fatigue, cognitive symptoms and bad days contemporaneously rather than reconstructing them; ask the neurologist for a detailed functional statement rather than a diagnosis letter; and plan the coverage bridge in advance — COBRA, a spouse’s plan, a marketplace plan with subsidies, or Medicaid. Confirm your own dates against your SSA notice, since the established onset date SSA assigns is what drives everything.
If a private disability policy exists, read its definition of disability now. "Own occupation" and "any occupation" definitions produce completely different outcomes, and many policies switch from one to the other after 24 months.
Myth 3: “The Drugs Will Bankrupt Us”
The list prices are genuinely extraordinary — published pricing analyses have put annual list prices for MS disease-modifying therapies in the range of roughly $70,000 to more than $100,000 as of the mid-2020s, and prices rose faster than inflation for years. Confirm current figures with the specialty pharmacy and the plan, as generics and biosimilars have begun to change this picture.
But list price is not what households pay, and the out-of-pocket picture changed materially in 2025.
For Medicare beneficiaries: the Part D out-of-pocket maximum became $2,000 in 2025, indexed annually thereafter — a hard annual cap that did not previously exist. Separately, the Medicare Prescription Payment Plan lets enrollees spread that out-of-pocket cost across the calendar year in monthly installments rather than paying it all in January. Confirm the current cap at Medicare.gov.
For commercially insured households: plans have their own out-of-pocket maximums, and manufacturer copay assistance is often available — but note the boundary, because it catches people at exactly the wrong moment: Medicare beneficiaries generally cannot use manufacturer copay coupons and must use independent charitable foundations instead. A household transitioning from commercial coverage to Medicare can lose copay assistance overnight. Plan that transition before it happens. See how specialty drug assistance works and its limits.
Also apply for Extra Help. The Part D low-income subsidy was expanded so that the full subsidy extends to 150 percent of the federal poverty level, effective 2024. Many people previously told they earned too much now qualify. Apply through Social Security; it is free.
| Myth | What is actually true | The action it changes | Confirm with |
|---|---|---|---|
| MS shortens life dramatically | Reduction commonly cited as years, not decades | Plan for a long horizon; preserve assets and coverage | Neurologist; National MS Society |
| Benefits start when work stops | Five-month SSDI wait, then 24 months to Medicare | Build a roughly 29-month coverage and income bridge | Social Security Administration |
| The drugs will bankrupt us | Part D out-of-pocket capped at $2,000 in 2025, indexed | Apply for Extra Help; use the payment plan | Medicare.gov; the specialty pharmacy |
| LTC insurance is still available | Generally declined after diagnosis | Mine existing riders; check employer guaranteed issue | Each carrier, in writing; HR |
| MS makes a policy valuable to sell | Pricing tracks impaired life expectancy, not diagnosis | Keep the policy in force; preserve the option | A free policy review |
| Nothing can be done until it worsens | Most valuable steps require current capacity | Documents, conversions and waiver lists now | Attorney; employer; state Medicaid agency |

Myth 4: “Long-Term Care Insurance Is Still an Option”
After an MS diagnosis, individual long-term care insurance is generally not available. Underwriting for LTC coverage is strict and a demyelinating disease is close to a categorical decline. The same is broadly true of new individual life and disability coverage.
Two narrow exceptions are worth chasing before assuming the door is shut. Employer group long-term care offerings sometimes include guaranteed issue at initial eligibility or during an open enrollment window — check with HR, and check the spouse’s employer too. And a life insurance policy already in force may contain a chronic illness or long-term care rider, which cannot be underwritten away after the fact.
What to do instead: treat existing in-force coverage as the asset it is. Pull every policy, request the rider schedule from each carrier in writing, and find out what benefit triggers apply. Most chronic illness and LTC riders trigger on the inability to perform a set number of activities of daily living — typically two of six — or on cognitive impairment requiring substantial supervision. That definition, not the diagnosis, is what pays. Read how activities of daily living are assessed, because the assessment is more mechanical than most people expect and preparation matters.
Then plan for the self-funded scenario. Recent published cost-of-care survey medians run roughly $33 to $35 an hour for a home health aide and roughly $5,900 a month for assisted living, varying widely by state. Confirm your own market. Full picture at how families pay for care without LTC insurance.
Myth 5: “MS Makes a Life Insurance Policy Valuable in the Secondary Market”
This is the myth that costs families the most, because it runs in the opposite direction from what people assume.
Secondary-market pricing tracks impaired life expectancy. A purchaser pays more when the projected period of premium payments is shorter. Because MS in most forms does not shorten life expectancy dramatically, a diagnosis of relapsing-remitting MS in a person in their forties or fifties typically produces either no offer or a low one. The diagnosis alone is not a valuation event.
What can change that is not the label but the clinical picture: advanced progressive disease, significant loss of function, recurrent hospitalization, aspiration or infection history, and the comorbidities that accumulate with prolonged immobility. Underwriters price physiology, not diagnoses.
What to do instead: do not plan around a sale, and be skeptical of anyone who suggests a diagnosis makes a policy worth cashing in. If circumstances genuinely change decades from now, the option still exists — but only if the policy is still in force. Preserving the policy preserves the option. Letting it lapse destroys it permanently and pays nothing.
If you want a straight read on where a specific policy stands today, a free review of the cover page will give you one, including the very common answer that there is no market for it now. Call (732) 978-9575.
Myth 6: “I Should Cash In the Policy to Pay for Care”
Sometimes true, usually premature, and there is an order of operations that most households skip.
Before any sale or surrender, check these in sequence. One: does the policy contain an accelerated death benefit, chronic illness or long-term care rider? Using a rider already in the contract costs nothing, requires no buyer and no new underwriting. Two: does the contract offer reduced paid-up or extended term nonforfeiture options that keep some coverage without further premiums? Three: what does a current in-force illustration show about how long the policy will last at the current funding level? Four: is there a waiver of premium rider that disability triggers, which may mean no premium is owed at all?
That fourth item is specific to this situation and it is missed constantly. Many policies sold to working-age adults carry a waiver of premium for disability. If the insured qualifies, the carrier pays the premium. Ask the carrier in writing whether the policy has one and what the claim process is.
Selling is clearly the wrong answer when: the face amount is under roughly $100,000, where the market rarely has interest; the policy is a small burial or final-expense contract already inside a benefits exclusion; the insured is comparatively healthy, which is the usual MS case; a spouse, a minor child or a disabled dependent still needs the death benefit; or a rider or waiver would solve the problem without giving up anything. And if a Medicaid application is likely, get an elder law attorney’s instruction first, because cash value counts as a resource once total face value exceeds the state’s threshold — commonly $1,500 — and a badly timed sale can create a look-back penalty. Confirm with the state Medicaid agency.
The parallel decision in a genetic neurological condition is walked through in planning around Huntington’s disease, where the insurability sequencing problem is even sharper.
Myth 7: “Nothing Can Be Done Until Things Get Worse”
The opposite is true: almost everything valuable in MS planning has to be done while function and capacity are good, and the list is short enough to complete in a month.
Documents, while capacity is unquestioned: a durable power of attorney with express insurance and banking powers, a health care proxy, a HIPAA authorization on file at every provider, and an up-to-date will. If a disabled adult child or a spouse will depend on assets, a special needs trust may be relevant — that belongs with an attorney.
Employment protections, while still working: reasonable accommodation under the Americans with Disabilities Act is available for MS, and fatigue, heat sensitivity and cognitive load are legitimate bases for accommodation. Intermittent FMLA leave — up to 12 workweeks a year for eligible employees of covered employers — is designed for exactly the relapsing pattern MS produces. Request the certification paperwork before it is urgent.
Coverage, while insurable: if any group life, disability or long-term care coverage is available at guaranteed issue through an employer, take it now. If a term policy is in force, get the conversion deadline from the carrier in writing; conversion to permanent coverage requires no new underwriting and the right expires quietly, often years before the term does.
Benefits, before the need: apply for Extra Help; learn the state’s Medicaid buy-in program for working people with disabilities, which many states operate and which lets someone work and keep coverage; and get on any home and community-based waiver interest list, since slots are capped and waits can run years.
Where several conditions accumulate over time, the valuation mechanics change — see how multiple conditions affect a policy valuation. And before acting on any of it, read when a life settlement is a bad idea, because for most people with MS, today, it is.
Frequently Asked Questions
Does an MS diagnosis make my life insurance policy worth selling?
Usually not. Secondary-market pricing tracks impaired life expectancy, and MS in most forms does not shorten life expectancy dramatically, so a diagnosis alone typically produces no offer or a low one. Underwriters price physiology rather than diagnosis labels. Keeping the policy in force preserves the option for the future; letting it lapse destroys it permanently and pays nothing.
How long is the gap between leaving work and getting Medicare?
Roughly 29 months in total: a five-month waiting period from the established onset of disability before SSDI payments begin, then 24 months from SSDI entitlement to Medicare. MS is not among the exceptions to the 24-month wait. Bridge it with COBRA, a spouse’s plan, a marketplace plan with subsidies, or Medicaid, and confirm your own dates on your SSA notice.
What will disease-modifying therapy actually cost me?
Far less than the list price. Published analyses put annual list prices in the range of roughly $70,000 to over $100,000 as of the mid-2020s, but the Part D out-of-pocket maximum became $2,000 in 2025 and is indexed annually. Commercially insured households have their own plan maximums and often copay assistance. Confirm current figures with the plan and the specialty pharmacy.
Can I still buy long-term care insurance after an MS diagnosis?
Individually, almost certainly not. Check two exceptions before assuming: employer group offerings sometimes provide guaranteed issue at initial eligibility or in an open enrollment window, including through a spouse’s employer, and an existing life policy may already contain a chronic illness or long-term care rider that cannot be underwritten away. Request every carrier’s rider schedule in writing.
Is there a way to stop paying premiums without losing the policy?
Possibly several. Many policies issued to working-age adults include a waiver of premium for disability, under which the carrier pays the premium if the insured qualifies. Contracts may also offer reduced paid-up or extended term options that preserve some coverage without further premiums. Ask the carrier in writing about all three before considering a surrender or sale.
What should I do first after a diagnosis, financially?
The things that require current capacity and insurability: execute a durable power of attorney with express insurance powers and a health care proxy, take any guaranteed-issue group coverage available at work, get the conversion deadline in writing for any term policy, request FMLA and accommodation paperwork, and apply for Extra Help. All of these expire quietly if deferred.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- Huntingtons Disease Family Planning
- Multiple Conditions And Valuation
- What Is An Activity Of Daily Living
- No Ltc Insurance Pay For Care
- Specialty Drug Copay Assistance
- What Is A Life Settlement
- When A Life Settlement Is A Bad Idea
- Home Care Hourly Cost Funding
Pine Lake Legacy does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.